Nutex Health (NUTX) Equity Average (2011 - 2026)

Nutex Health has disclosed Equity Average across 15 years of filings, most recently posting $432.7 million for Q1 2026.

• Equity Average for Q1 2026 came in at $432.7 million, up 95.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $432.7 million (up 95.02% YoY), and the FY2025 annual result was $306.0 million, up 128.66% from the prior year.
• Equity Average came in at $432.7 million for Q1 2026 at Nutex Health, roughly flat from $430.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $432.7 million in Q1 2026 to a low of $79.6 million in Q1 2024.
• The 5-year median for Equity Average is $134.2 million (2024), against an average of $211.7 million.
• Across the five-year window, Equity Average tumbled 70.71% in 2023 and soared 378.93% in 2025, its largest moves.
• Nutex Health's Equity Average stood at $126.4 million in 2022, then decreased by 27.23% to $92.0 million in 2023, then surged by 45.81% to $134.2 million in 2024, then soared by 221.07% to $430.7 million in 2025, then increased by 0.47% to $432.7 million in 2026.
• The last three Equity Average figures came in at $432.7 million (Q1 2026), $430.7 million (Q4 2025), and $387.5 million (Q3 2025), per Business Quant data.